www.sciencedaily.com
Stanford researchers achieved a breakthrough in mice, potentially curing or preventing Type 1 diabetes with a dual transplant of blood stem and islet cells. This innovative approach generates a hybrid immune system, effectively halting autoimmune attacks that target insulin-producing cells. A significant advantage is the elimination of immunosuppressant drugs typically required after transplants. Utilizing existing clinical tools, this research paves the way for human trials. Beyond diabetes, scientists believe this method could revolutionize the treatment of other autoimmune diseases and improve outcomes in organ transplantation by reducing or eliminating the need for anti-rejection medications.
